← Return to IPMNs, concerned for diffuse pancreatic parenchymal atrophy
DiscussionIPMNs, concerned for diffuse pancreatic parenchymal atrophy
Pancreatic Cancer | Last Active: May 29 10:44am | Replies (10)Comment receiving replies
Replies to "An MRI or MRCP is the method of choice in accurately assessing whether an IPMN is..."
Thank you for your comment. The concern is actually not the IPMN's as far as I know-they are >5mm. The concern is for a mass or stricture likely in the area where the head/duct meets the small intestine from what they have told me (I spoke with them after I posted this). The reason they are thinking this is because of increased duct dilatation in the pancreas, liver CBD, and intrahepatic ducts. So they think it is a pressure issue downstream from the liver. My confusion is why last year's EUS/ERCP didn't show any obstruction or this new ERCP. Is it possible that without any suspicion of a stricture, that area was not looked at? Or maybe that area is hard to image and something like a stone could hide there.